Skip to content
Back to meeting Original
Nature Medicine· @NatureMedicine · X·· 1 day agoScore45
Body

At #ESMO26: In an analysis of the phase 3 RELATIVITY-047 trial comparing relatlimab + nivolumab vs nivolumab alone in patients with melanoma, high baseline levels of LAG3hi CD8+ T cells were associated with improved response in the combination arm dlvr.​it/TW34gN

340 views · 0 likes · 0 reposts · 0 replies

Source: Nature Medicine · x.com

CBACBA Frontier Insights (CFI)Chinese Biopharmaceutical Association (CBA)www.cba-usa.org

Disclaimer CBA Frontier Insights uses AI-assisted methods to aggregate, summarize, and analyze publicly accessible biopharmaceutical information. Content is provided for informational and educational purposes only and does not represent the official views of original sources or affiliated organizations. AI-generated content may contain errors; please verify important information against primary sources. Intellectual property rights remain with their respective owners. For copyright concerns or corrections, please contact us through the website’s feedback page.